# Afya Ltd > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/fi/companies/Afya Ltd). ## Overview Afya Ltd is a Brazil-focused medical education and physician-services company organized around medical school seats, residency preparation, continuing medical education, and practice-support tools for doctors. It operates an end-to-end ecosystem that follows students from medical school through professional practice, with its core operating assets and learners concentrated in Brazil. ## Products & services • Medical school seats and undergraduate medical education • Medical residency preparation and graduate programs • Continuing medical education for physicians • Medical practice solutions and workflow support tools - **Medical education** (55%) — Undergraduate medical programs and approved medical school seats in Brazil. - **Residency and graduate preparation** (15%) — Programs and content that help medical students prepare for residency and postgraduate training. - **Continuing medical education** (15%) — Educational offerings for practicing physicians seeking professional development and certification support. - **Medical practice solutions** (15%) — Tools and services that support doctors in managing and improving clinical practice. - Medical school seats and undergraduate medical education - Medical residency preparation and graduate programs - Continuing medical education for physicians - Medical practice solutions and workflow support tools ## Customers Afya sells primarily to medical students, residents, and practicing physicians in Brazil. It also serves doctors and healthcare professionals who buy continuing education content and practice-support solutions to improve their clinical work and professional development. - **Medical students** (primary) — Buy undergraduate medical seats and related academic services to obtain a physician degree. - **Residency candidates and graduates** (secondary) — Buy preparation programs and graduate offerings to improve residency placement and career progression. - **Practicing physicians** (primary) — Buy continuing education and practice solutions to support clinical learning and service quality. - **Healthcare professionals** (secondary) — Use Afya’s physician-centric ecosystem for professional development across the medical career lifecycle. - Medical students seeking accredited seats and degree pathways - Residents and graduates preparing for competitive residency exams - Practicing physicians buying continuing education and updates - Doctors using practice solutions to improve service delivery - Healthcare professionals seeking a long-term career platform ## Geography Afya’s business is centered in Brazil, where it operates medical education campuses and serves physicians across the country. The reports identify multiple Brazilian locations, including Abaetetuba in Pará and Belo Horizonte in Minas Gerais, underscoring that geography matters mainly through local campus approvals, seat allocations, and regulatory oversight. - **Brazil** (100%) — Company reports describe Afya as Brazil-based and operating in Brazil. - Brazil is the core market for students, physicians, and campuses - Campuses are tied to local regulatory approvals for medical seats - Reported locations include Pará and Minas Gerais in Brazil - Revenue is driven by Brazilian operations and functional currency - Local health-region capacity affects expansion and seat utilization ## Strategy Afya’s strategy centers on expanding approved medical school seats while deepening its physician-centric ecosystem across education and practice support. The company also appears focused on pairing regulated education assets with recurring professional services that keep doctors connected to the platform after graduation. - **Increase medical seat capacity** (short-term) — More approved seats directly expand the core education platform and future student intake. - **Grow the physician lifecycle platform** (medium-term) — Serving doctors after graduation improves retention and widens monetization beyond tuition. - **Maintain regulatory alignment** (medium-term) — Medical education capacity depends on ministry approvals and health-region constraints. - Expand approved medical seats to increase capacity and reach - Use campus approvals and regulatory relationships as a growth lever - Build a lifetime physician ecosystem beyond the classroom - Cross-sell residency, CME, and practice solutions to alumni - Strengthen national scale in Brazil’s medical education market ## Risks Afya’s main risks are regulatory, because medical school seats depend on government approvals and campus-specific operating permissions. The business is also exposed to concentration in Brazil, competition for medical students, and the challenge of keeping the education platform relevant across a doctor’s full career. - **Regulatory approval risk for medical seats** [high] — Core capacity growth depends on Ministry of Education authorization and compliance with local requirements. - **Brazil concentration** [high] — Operations, students, and revenue are concentrated in one country, increasing sensitivity to local policy and macro conditions. - **Competition for students and physicians** [medium] — Alternative education providers and digital offerings can pressure enrollment and retention. - **Execution risk in lifecycle monetization** [medium] — The physician-centric model requires successful cross-sell from students to practicing doctors. - Medical seat approvals depend on Brazilian regulators and permits - Campus expansion can be constrained by local health-region rules - Brazil concentration creates country-specific regulatory exposure - Enrollment demand and pricing can shift with competition - Practice solutions must stay relevant to physicians over time ## Accounting Afya’s financial reporting involves judgment around intangible assets, goodwill, and licenses with indefinite useful lives, all of which can affect asset values and impairment testing. The company also uses non-GAAP measures such as Adjusted EBITDA and Operating Cash Conversion Ratio, so investors should separate those management metrics from IFRS results and watch how recurring education revenues and acquisition-related items flow through the statements. - **Indefinite-life intangible assets** — Reported asset values and impairment charges - **Non-GAAP performance measures** — Investor interpretation of operating performance and cash generation - **Acquisition and investment accounting** — Balance sheet values and periodic remeasurement gains or losses - License valuation relies on with-and-without fair value methods - Indefinite-life intangibles require ongoing impairment testing - Acquisition accounting can affect goodwill and future amortization - Non-GAAP measures may differ from IFRS earnings and cash flow - Brazilian reais are the functional and presentation currency --- *Last updated: 2026-09-28T11:57:37.013143+00:00*